Home
About
Overview
Sharing Data
ORCID
Help
History (24)
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
Jaundice, Chronic Idiopathic
Hypogastric Plexus
Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance.
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance.
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance. Trends Cancer. 2023 01; 9(1):42-54.
View in:
PubMed
subject areas
Cross Reactions
Drug Resistance, Neoplasm
Humans
Medical Oncology
Neoplasms
Precision Medicine
Proto-Oncogene Proteins p21(ras)
authors with profiles
Ravi Salgia